| 31/12/2004 | 31/12/2005* | Proforma | ||
| In EUR millions | IFRS | IFRS | % change | 2005** |
| Sales | 34.80 | 50.15 | + 44.1% | 63.40 |
| Gross margin | 21.70 | 30.97 | + 42.7% | 37.7 |
| as a % of sales | 62.4% | 61.8% | 59.4% | |
| Operating income | 4.72 | 6.54 | + 38.6% | 8.08 |
| as a % of sales | 13.6% | 13.0% | 12.7% | |
| Consolidated net income | 3.08 | 4.01 | + 30.2% | 4.64 |
| as a % of sales | 8.8% | 8.01% | 7.3% | |
| Group net income | 2.95 | 3.95 | + 33.9% | 4.58 |
| as a % of sales | 8.5% | 7.9% | 7.2% | |
|
* Pure World consolidated over six months ** Including full-year integration of Pure World |
||||
Over 2005 as a whole, Naturex generated sales of EUR 50.15 million, an increase of 44.1%, including the 6-month consolidation of Pure World. At constant USD exchange rates, growth comes out at 45.7%.
In proforma terms, sales increased by 82.2% and reached EUR 63.40 million of which 71% was generated in the USA and Canada. Nutraceuticals now account for 61% of activity and food ingredients for 33%.
In 2005, Naturex achieved further high returns despite making a major acquisition. Concurrently, it also achieved high levels (+10.4%) of organic growth.
During the financial year the operating margin came out at 13.0%, while over the same period net income grew by 30.2% to EUR 4.01 million, and by over 50% on the basis of proforma accounts, in line with forecasts.
The Integration of Pure World is progressing faster than forecast and should be completed six months ahead of the initial timetable of between 18 and 24 months.
A very good start to the 2006 year
| January/February | January/ | % change | |
| In EUR millions | Proforma 2005 | February 2006 | |
| Sales | 8.87 | 11.52 | + 29.9% |
In the first two months of the current financial year, organic growth stood at 19.6% at constant USD exchange rates and at almost 30% in current USD terms.
At constant USD exchange rates Naturex is forecasting further sustained organic growth of 10-15% throughout fiscal year 2006, along with an increase of between 20% and 30% in net income.
Naturex will announce its sales for the first quarter of 2006 on 25 April.
About Naturex
Naturex manufactures and markets 100% natural plant extracts for the food, flavour, nutraceuticals and cosmetics industries. Headquartered in Avignon, France, Naturex is an international company generating over 90% of its sales in 30 countries outside France, with 70% of sales on the North American market. Naturex operates manufacturing facilities in France, Morocco and the United States, and a representative office in Singapore.
If you would like to receive financial information about Naturex by e-mail, contact: www.kaparcafinance.com
Your contacts
|
Naturex Contact: Thierry Lambert on +33 (0)4 90 23 96 89 t.lambert@naturex.com Kaparca Finance Contact: Laurence Marquézy on +33 (0)1 72 74 82 23 lmarquezy@kaparcafinance.com NATUREX listed in 1996 on the Euronext Paris Eurolist, Compartment C ISIN: FR0000054694 Reuters: NATU.LN Bloomberg: NTRX Kaparca Finance 27th March 2006 |